Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Rayzzeron Jan 17, 2018 11:06am

119 Views

Post# 27376534

RE:RE:RE:what happened to the 4 patient efficacy ?

vestor111 wrote: The inspection can be held within a +/-7 day window to allow for scheduling needs. We are within the window (with 180 day = Jan 20 per the board)

Not that a few days really matters but Jan 16th (yesterday) was 180 days since the fourth patient was treated. Aug 1st NR stated July 20th was the treatment date.

Bullboard Posts

Victoria Gold: No cyanide detected downstream since mine incident